Reviewing Quidel


Quidel and Nymox Pharmaceutical are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, earnings, dividends and risk. Quidel has a beta of 0.89, meaning that its stock price is 11% less volatile than the S&P 500.



from Biotech News